What is Tulsa Pain?
Tulsa Pain Consultants operates as a premier interventional pain clinic, distinguishing itself through a comprehensive suite of minimally invasive treatments. The practice focuses on addressing complex conditions such as chronic back and neck pain, as well as arthritis, utilizing advanced modalities including Radiofrequency Ablation, Peripheral Nerve Stimulation, and Platelet-Rich Plasma therapy. By prioritizing board-certified expertise and innovative, evidence-based solutions, the clinic has established a reputation for restoring functional mobility and enhancing the overall quality of life for its patient base. Their market position is defined by a commitment to compassionate care, effectively bridging the gap between traditional pain management and cutting-edge medical technology.
How much funding has Tulsa Pain raised?
Tulsa Pain has raised a total of $814K across 2 funding rounds:
Debt
$350K
Debt
$464K
Debt (2020): $350K with participation from PPP
Debt (2021): $464K led by PPP
Key Investors in Tulsa Pain
PPP
Public-Private Partnership
What's next for Tulsa Pain?
With the recent capital injection, Tulsa Pain is well-positioned to accelerate its strategic growth initiatives. The organization is expected to focus on the optimization of its clinical service delivery, potentially expanding its capacity for specialized procedures and investing in the latest medical equipment to maintain its competitive edge. Furthermore, the firm will likely prioritize the integration of advanced patient safety protocols and the refinement of its operational workflows to accommodate increasing demand. As the clinic continues to scale, the focus will remain on balancing rapid growth with the maintenance of its high standards for patient comfort and clinical efficacy, ensuring long-term sustainability in the highly competitive interventional pain management market.
See full Tulsa Pain company page
